Invesaro

Stocks DAO Financial statements

Financial statements

Youdao, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Youdao, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue187485630727759771845
Cost of revenue134263318352369394471
Gross profit53.2223312375390377374
Research and development39.665.195.31171057473.5
Selling and marketing89.5413326338320257241
General and administrative10.521.229.933.231.325.628.2
Operating expenses140500460487455356343
Operating income-86.3-277-148-112-65.720.431.6
Interest expense4.784.976.619.79109.01
Interest income3.912.951.871.180.540.35
Other non-operating income2.889.365.7611.8-1.630.22-6.74
Pre-tax income-268-144-105-75.911.116.2
Income tax0.350.451.042.011.560.822.37
Net income to minority interests0.01-0.09-4.82-2.73-0.03-0.96-1.47
Net income-86.4-269-156-105-77.511.315.4
EBITDA-84.8-274-143-106-61.524.435
EPS, basic-0.96-2.38-1.28-0.85-0.640.100.13
EPS, diluted-0.96-2.38-1.28-0.85-0.640.100.13
Shares, basic (weighted)95.4113122124121117118
Shares, diluted (weighted)95.4113122124121118120

Balance sheet

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents24.993.450.71146481.262.9
Short-term investments17.489.779.133.710.18.6442.7
Receivables28.841.23958.749.957.454.5
Inventory10.522.840.133.730.623.920.1
Other current assets17.436.128.730.124.721.119.9
Total current assets292284356271183204246
Property, plant and equipment3.536.99
Lease right-of-use assets3.4316.218.511.412.59.386.71
Goodwill17.315.915.515.115.7
Long-term investments6.515.113.27.249.922.83
Other non-current assets1.173.793.525.086.344.124.47
Total assets300317413330235249282
Accounts payable921.725.340.922.419.915.7
Accrued liabilities13.632.143.538.639.836.242.2
Deferred revenue65.6221167155148132121
Total current liabilities253520476461437404420
Lease liabilities3.0512.211.56.336.953.52.69
Other non-current liabilities0.790.620.381.282.32.494.12
Total liabilities256533528544535535559
Paid-in capital321354614579568554580
Treasury stock-6.14-24.2-28.9-25.2
Other comprehensive income-7.21-8.53-13.4-14.2-15.3-14.3
Minority interests0.130.15-0.3-0.982.776.945.71
Total equity43.2-216-127-224-305-286-277
Total liabilities and equity300317413330235249282
Shares outstanding112115123123119118119

Cash flow statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-86.4-269-161-108-77.510.313.9
Depreciation and amortization1.522.474.726.124.183.973.35
Stock-based compensation3.66.3711.310.34.343.14.96
Deferred income tax-1.41
Change in receivables-17.5-12.33.9-23.76.2-9.382.91
Change in inventory-7.55-11.1-232.91.233.42.61
Change in payables4.0412.11.9517.6-17.4-1.9-5.04
Cash from operations-53.5-49.3-211-87.4-61.7-9.37.89
Capital expenditures-2.61-5.65-9.96-9.95-2.51-1.62-3.66
Acquisitions-0.986.78-0.59
Purchases of investments-31-258-122-182-15.5-3.43-48.2
Cash from investing-1561177.3918.217.7-1.86-36.2
Share buybacks-7.35-18-8.54
Cash from financing2284.0728026.8-2.6731.36.53
Net change in cash18.966.872.7-41.8-46.419.8-22.1
Free cash flow-56.1-54.9-221-97.4-64.2-10.94.23
Interest paid4.284.384.485.718.9212.98.86
Income taxes paid0.71.281.521.371.791.62.49

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $14.70 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin44.3%Gross profit / revenue.
Operating margin3.7%Operating income / revenue.
EBITDA margin4.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.9%Pre-tax income / revenue.
Net margin1.8%Net income / revenue.
FCF margin0.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin0.9%Cash from operations / revenue.
Effective tax rate14.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)5.8%Net income / average total assets.
R&D / revenue8.7%Research and development expense / revenue.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.4%Capital expenditures / revenue.
D&A / revenue0.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y9.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y5.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-0.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-0.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y10.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y55.2%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y43.7%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y36.3%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y30.0%EPS vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y13.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-5.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y1.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.59xCurrent assets / current liabilities.
Quick ratio0.38x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.25x(Cash + short-term investments) / current liabilities.
Liabilities / assets197.9%Total liabilities / total assets.
Interest coverage3.51xOperating income / interest expense.
Working capital-$173.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets5.6%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover3.18xRevenue / average total assets.
Inventory turnover21.4xCost of revenue / average inventory.
Days inventory17 days365 x average inventory / cost of revenue.
Receivables turnover15.1xRevenue / average receivables.
Days sales outstanding24 days365 x average receivables / revenue.
Days payables14 days365 x average accounts payable / cost of revenue.
Cash conversion cycle27 daysDays inventory + days sales outstanding - days payables.
FCF conversion27.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow46.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.13Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.13Net income per basic share, as reported (split-adjusted).
Revenue per share$7.05Revenue / diluted weighted shares.
FCF per share$0.04Free cash flow / diluted weighted shares.
Operating cash flow per share$0.07Cash from operations / diluted weighted shares.
Cash per share$0.89(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.77BShare price x shares outstanding.
Enterprise value$1.67BMarket cap + total debt - cash - short-term investments.
P/E116xMarket cap / net income. Only when net income is positive.
P/S2.10xMarket cap / revenue.
P/FCF419xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF225xMarket cap / cash from operations, when positive.
EV/Sales1.97xEnterprise value / revenue.
EV/EBIT52.7xEnterprise value / operating income, when both are positive.
EV/EBITDA47.7xEnterprise value / EBITDA, when both are positive.
EV/FCF394xEnterprise value / free cash flow, when both are positive.
FCF yield0.2%Free cash flow / market cap.
Earnings yield0.9%Net income / market cap (the inverse of P/E).
What was Youdao, Inc.'s revenue in fiscal 2025?

Youdao, Inc. reported revenue of $845.0M for fiscal 2025, 9.6% higher than the year before.

Was Youdao, Inc. profitable in fiscal 2025?

Yes. Net income was $15.4M, a net margin of 1.8%.

How much free cash flow did Youdao, Inc. generate in fiscal 2025?

Cash from operations of $7.9M minus capital expenditures of $3.7M left free cash flow of $4.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Youdao, Inc.